A high prevalence of genes, namely, PIK3CA, EP300, FBXW7, and PTEN was identified as the genomic feature of Western cervical cancer patients, and inferred as novel potential therapeutic targets for drug development in future. This evidence concerns the gene PIK3CA and cervical cancer.